세라마이드 시장 규모, 점유율, 동향, 예측 : 유형, 프로세스, 용도, 지역별(2025-2033년)

The global ceramide market size was valued at USD 412.3 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 628.8 Million by 2033, exhibiting a CAGR of 4.56% during 2025-2033. Asia Pacific currently dominates the market, holding a significant market share of 37.3% in 2024. At present, Asia Pacific holds the largest ceramide market share owing to increasing awareness for skin health, robust manufacturing capabilities, supportive government initiatives, and favorable demographics.

Ceramides are lipids found naturally in cell membranes and composed of sphingosine alcohol with fatty acids. They aid in mediating various cellular processes affecting cell differentiation and apoptosis. As a result, they are utilized in liver steatosis, obesity-associated comorbidities, regulating inflammation, and oxidizing impaired fatty acid. Moreover, they are used as a moisturizing agent in various cosmetic and personal products to help treat different skin and hair problems caused by chronic dryness, environmental factors, aging, and skin damage.

Ceramide Market Trends:

Individuals who suffer from eczema and psoriasis have a significant reduction of ceramides in their skin. Thus, the rising prevalence of eczema and psoriasis on account of the increasing number of people that drink and smoke represents one of the key factors catalyzing the usage of ceramides in dermatological products. In line with this, as naturally occurring ceramides decline with age, the growing geriatric population is driving the demand for ceramide-based products to improve water retention, restore the skin's natural barrier, and reduce the visible signs of aging. Additionally, the emerging trend of vegan cosmetics is positively influencing the adoption of ceramides as they are synthetically produced without the use of animal byproducts. Besides this, as diabetes mellitus is one of the leading causes of death worldwide, there is a rise in the utilization of ceramides in the pharmaceutical industry. Furthermore, ceramides play a significant role in insulin resistance, induction of B-cell apoptosis, and the reduction of insulin gene expression, which assists in identifying potential therapeutic targets for managing diabetes mellitus and its complications. Apart from this, due to rising health consciousness among individuals, ceramides are widely being used in supplements that promote a healthier life.

Key Market Segmentation:

Breakup by Type:

• Natural
• Synthetic

Breakup by Process:

• Fermentation Ceramides
• Plant Extract Ceramides

Breakup by Application:

• Cosmetics
• Food
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Air Liquide S.A., Anderson Global Group LLC, Arkema S.A., Ashland Inc., Cayman Chemical Company, Croda International Plc, Evonik Industries AG, Incospharm Corporation, Jarchem Industries Inc., Kao Corporation, Toyobo Co. Ltd. and Vantage Specialty Chemicals.

Key Questions Answered in This Report

• 1.How big is the ceramide market?
• 2.What is the future outlook of the ceramide market?
• 3.What are the key factors driving the ceramide market?
• 4.Which region accounts for the largest ceramide market share?
• 5.Which are the leading companies in the global ceramide market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Ceramide Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Natural
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Synthetic
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Process

• 7.1 Fermentation Ceramides
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Plant Extract Ceramides
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Application

• 8.1 Cosmetics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Food
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Air Liquide S.A.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Anderson Global Group LLC
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Arkema S.A.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Ashland Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Cayman Chemical Company
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Croda International Plc
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Evonik Industries AG
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Incospharm Corporation
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Jarchem Industries Inc.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Kao Corporation
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Toyobo Co. Ltd.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis
  • 14.3.12 Vantage Specialty Chemicals
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio